Se-cure Pharmaceuticals is a clinical-stage, technology-driven pharmaceutical company focused on developing safe and effective therapeutic solutions derived from botanical sources. By implementing proprietary botanical drug development and scaling technologies, Se-cure seeks to introduce novel biochemical agents characterized by selective mechanisms of action in the target tissues. The company's methodology for developing drugs from botanical sources is in accordance with US FDA botanical drug development guidelines. Se-cure establishes large-scale human and post-marketing data by using over-the-counter pilot sales of its botanical therapeutics, helping the company produce both efficacy and safety data and substantially increasing the agent's probability of success in phase-3 studies. Se-cure's current pipeline includes six botanical drug candidates whose targets include women's health and osteoporosis management, men's health and benign hyperplasia management, burn injury management, and dental bone rejuvenation.